Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center

Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center

Background/Objectives: Locally advanced and metastatic leiomyosarcoma (LMS) is an aggressive cancer with limited treatment options. This single-institution, retrospective study evaluated the efficacy of first-line chemotherapy regimens in patients with advanced or metastatic LMS treated at Stanford...

Full description

Saved in:
Bibliographic Details
Main Authors: Ted Kim, Clara Hao, Minggui Pan, Kristen N. Ganjoo, Nam Q. Bui
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Diseases
Subjects:
leiomyosarcoma
soft tissue sarcoma
chemotherapy
doxorubicin
progression-free survival
overall survival
Online Access:https://www.mdpi.com/2079-9721/13/3/79
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items